Natdac is a medication used in the treatment of chronic hepatitis C virus (HCV) infection. It contains the active substance Daclatasvir Dihydrochloride and is manufactured by Natco Pharma Ltd. Natdac tablets are available in a pack of 28 tablets, with each tablet containing 60 mg of Daclatasvir.
– Treatment of chronic hepatitis C virus (HCV) infection
– Used in combination with other antiviral medications to achieve sustained virologic response (SVR)
– Reduces the viral load and prevents the replication of the hepatitis C virus
– Improves liver function and reduces the risk of long-term complications
How to use:
Natdac is taken orally, usually once a day, with or without food. The recommended dosage is one tablet daily. It is crucial to comply with the prescribed dosage and to continue the medication for the duration as directed by a healthcare professional.
Store Natdac in a cool, dry place at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Mechanism of action:
Daclatasvir, the active substance in Natdac, belongs to a class of medications called direct-acting antivirals (DAAs). It works by inhibiting the NS5A protein, which is essential for viral replication, assembly, and secretion. By blocking the action of NS5A, Daclatasvir helps to reduce the viral load and prevent the spread of the hepatitis C virus in the body. This ultimately leads to the suppression of the virus, improvement in liver function, and a higher chance of achieving sustained virologic response (SVR).
– Natdac should be used with caution in patients with a history of liver or kidney disease.
– Inform the healthcare provider of all medications being taken, as Natdac can interact with certain drugs.
– Hypersensitivity to Daclatasvir or any of the ingredients in the medication
– Use in pregnant women, unless specifically instructed by a healthcare professional
– Use in breastfeeding women, as the safety of Daclatasvir during breastfeeding has not been established
– Natdac can interact with several medications, including those that affect liver enzymes, anticonvulsants, and certain antibiotics. Inform the healthcare provider of all medications being used before starting Natdac.
In case of an overdose, seek emergency medical attention immediately. There is limited information available on the effects of Natdac overdose. However, standard supportive measures should be initiated if deemed necessary.
– Abdominal pain
– Muscle pain
In conclusion, Natdac is a medication used in the treatment of chronic hepatitis C virus (HCV) infection. It contains Daclatasvir Dihydrochloride and is manufactured by Natco Pharma Ltd. It is crucial to follow the prescribed dosage and to continue the medication for the duration as directed by a healthcare professional. Natdac is generally well-tolerated, but it can cause some side effects. Regular monitoring of liver function is necessary, and caution should be exercised in patients with pre-existing liver or kidney conditions.